ArticleNeuroendocrinology2022

A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms.

Xianlong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.